nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—hematologic cancer—Methylprednisolone—atopic dermatitis	0.136	0.238	CpDpCtD
Celecoxib—kidney cancer—Hydrocortisone—atopic dermatitis	0.0726	0.127	CpDpCtD
Celecoxib—ORM1—Tacrolimus—atopic dermatitis	0.0621	0.25	CbGbCtD
Celecoxib—colon cancer—Dexamethasone—atopic dermatitis	0.0613	0.107	CpDpCtD
Celecoxib—colon cancer—Betamethasone—atopic dermatitis	0.0613	0.107	CpDpCtD
Celecoxib—prostate cancer—Hydrocortisone—atopic dermatitis	0.0525	0.0917	CpDpCtD
Celecoxib—kidney cancer—Dexamethasone—atopic dermatitis	0.0443	0.0774	CpDpCtD
Celecoxib—kidney cancer—Betamethasone—atopic dermatitis	0.0443	0.0774	CpDpCtD
Celecoxib—prostate cancer—Dexamethasone—atopic dermatitis	0.032	0.056	CpDpCtD
Celecoxib—prostate cancer—Betamethasone—atopic dermatitis	0.032	0.056	CpDpCtD
Celecoxib—ALB—Tacrolimus—atopic dermatitis	0.0261	0.105	CbGbCtD
Celecoxib—PTGS2—Triamcinolone—atopic dermatitis	0.021	0.0847	CbGbCtD
Celecoxib—PTGS2—Betamethasone—atopic dermatitis	0.018	0.0727	CbGbCtD
Celecoxib—osteoarthritis—Methylprednisolone—atopic dermatitis	0.018	0.0315	CpDpCtD
Celecoxib—osteoarthritis—Prednisone—atopic dermatitis	0.018	0.0315	CpDpCtD
Celecoxib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0138	0.0555	CbGbCtD
Celecoxib—ALB—Prednisone—atopic dermatitis	0.0106	0.0427	CbGbCtD
Celecoxib—PTGS2—Dexamethasone—atopic dermatitis	0.0105	0.0423	CbGbCtD
Celecoxib—CYP2C9—Loratadine—atopic dermatitis	0.0103	0.0416	CbGbCtD
Celecoxib—CYP2C9—Diphenhydramine—atopic dermatitis	0.0103	0.0416	CbGbCtD
Celecoxib—CYP2D6—Diphenhydramine—atopic dermatitis	0.00943	0.038	CbGbCtD
Celecoxib—CYP2D6—Loratadine—atopic dermatitis	0.00943	0.038	CbGbCtD
Celecoxib—CYP3A4—Tacrolimus—atopic dermatitis	0.00819	0.033	CbGbCtD
Celecoxib—CYP3A4—Loratadine—atopic dermatitis	0.00599	0.0242	CbGbCtD
Celecoxib—CYP3A4—Methylprednisolone—atopic dermatitis	0.00548	0.0221	CbGbCtD
Celecoxib—CYP3A4—Triamcinolone—atopic dermatitis	0.00416	0.0167	CbGbCtD
Celecoxib—CYP2C9—Dexamethasone—atopic dermatitis	0.00357	0.0144	CbGbCtD
Celecoxib—CYP3A4—Betamethasone—atopic dermatitis	0.00356	0.0144	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—atopic dermatitis	0.00352	0.0142	CbGbCtD
Celecoxib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00333	0.0134	CbGbCtD
Celecoxib—CYP3A4—Prednisone—atopic dermatitis	0.00332	0.0134	CbGbCtD
Celecoxib—CYP2D6—Dexamethasone—atopic dermatitis	0.00326	0.0131	CbGbCtD
Celecoxib—CA6—ear—atopic dermatitis	0.0032	0.325	CbGeAlD
Celecoxib—CYP3A4—Dexamethasone—atopic dermatitis	0.00207	0.00836	CbGbCtD
Celecoxib—MAPK14—neck—atopic dermatitis	0.001	0.102	CbGeAlD
Celecoxib—PDPK1—head—atopic dermatitis	0.00079	0.0802	CbGeAlD
Celecoxib—MAPK14—skin of body—atopic dermatitis	0.000648	0.0657	CbGeAlD
Celecoxib—PTGS2—skin epidermis—atopic dermatitis	0.000601	0.061	CbGeAlD
Celecoxib—CA6—head—atopic dermatitis	0.000478	0.0485	CbGeAlD
Celecoxib—CA4—neck—atopic dermatitis	0.00047	0.0477	CbGeAlD
Celecoxib—MAPK14—head—atopic dermatitis	0.000423	0.0429	CbGeAlD
Celecoxib—CA2—neck—atopic dermatitis	0.00039	0.0396	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000365	0.165	CbGdCrCtD
Celecoxib—CA12—head—atopic dermatitis	0.000321	0.0325	CbGeAlD
Celecoxib—CA5B—head—atopic dermatitis	0.000288	0.0292	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000284	0.128	CbGdCrCtD
Celecoxib—CA2—skin of body—atopic dermatitis	0.000252	0.0256	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000227	0.102	CbGdCrCtD
Celecoxib—ABCC4—head—atopic dermatitis	0.000216	0.0219	CbGeAlD
Celecoxib—CA4—head—atopic dermatitis	0.000199	0.0201	CbGeAlD
Celecoxib—PTGS2—skin of body—atopic dermatitis	0.000186	0.0189	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000176	0.0797	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000171	0.0774	CbGdCrCtD
Celecoxib—CA2—head—atopic dermatitis	0.000165	0.0167	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000137	0.0618	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000135	0.0612	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000133	0.0602	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000133	0.0602	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.00013	0.0588	CbGdCrCtD
Celecoxib—PTGS2—head—atopic dermatitis	0.000122	0.0123	CbGeAlD
Celecoxib—CYP2D6—head—atopic dermatitis	0.000104	0.0106	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	8.17e-05	0.0369	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	8.04e-05	0.0363	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	8.04e-05	0.0363	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	7.85e-05	0.0355	CbGdCrCtD
Celecoxib—Hypertension—Hydrocortisone—atopic dermatitis	4.09e-05	0.00035	CcSEcCtD
Celecoxib—Angioedema—Triamcinolone—atopic dermatitis	4.08e-05	0.000349	CcSEcCtD
Celecoxib—Haemoglobin—Prednisone—atopic dermatitis	4.07e-05	0.000349	CcSEcCtD
Celecoxib—Angioedema—Methylprednisolone—atopic dermatitis	4.07e-05	0.000348	CcSEcCtD
Celecoxib—Haemorrhage—Prednisone—atopic dermatitis	4.05e-05	0.000347	CcSEcCtD
Celecoxib—Myalgia—Hydrocortisone—atopic dermatitis	4.04e-05	0.000345	CcSEcCtD
Celecoxib—Hallucination—Prednisone—atopic dermatitis	4.03e-05	0.000345	CcSEcCtD
Celecoxib—Anxiety—Hydrocortisone—atopic dermatitis	4.02e-05	0.000344	CcSEcCtD
Celecoxib—Vertigo—Triamcinolone—atopic dermatitis	4.01e-05	0.000343	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.01e-05	0.000343	CcSEcCtD
Celecoxib—Syncope—Triamcinolone—atopic dermatitis	4e-05	0.000343	CcSEcCtD
Celecoxib—Vertigo—Methylprednisolone—atopic dermatitis	4e-05	0.000342	CcSEcCtD
Celecoxib—Syncope—Methylprednisolone—atopic dermatitis	3.99e-05	0.000342	CcSEcCtD
Celecoxib—Connective tissue disorder—Prednisone—atopic dermatitis	3.98e-05	0.000341	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisolone—atopic dermatitis	3.96e-05	0.000339	CcSEcCtD
Celecoxib—Oedema—Prednisolone—atopic dermatitis	3.96e-05	0.000339	CcSEcCtD
Celecoxib—Vomiting—Tacrolimus—atopic dermatitis	3.94e-05	0.000337	CcSEcCtD
Celecoxib—Loss of consciousness—Triamcinolone—atopic dermatitis	3.92e-05	0.000336	CcSEcCtD
Celecoxib—Loss of consciousness—Methylprednisolone—atopic dermatitis	3.91e-05	0.000335	CcSEcCtD
Celecoxib—Rash—Tacrolimus—atopic dermatitis	3.91e-05	0.000335	CcSEcCtD
Celecoxib—Dermatitis—Tacrolimus—atopic dermatitis	3.91e-05	0.000334	CcSEcCtD
Celecoxib—Shock—Prednisolone—atopic dermatitis	3.9e-05	0.000334	CcSEcCtD
Celecoxib—Cough—Triamcinolone—atopic dermatitis	3.89e-05	0.000333	CcSEcCtD
Celecoxib—Headache—Tacrolimus—atopic dermatitis	3.88e-05	0.000333	CcSEcCtD
Celecoxib—Oedema—Hydrocortisone—atopic dermatitis	3.87e-05	0.000331	CcSEcCtD
Celecoxib—Anaphylactic shock—Hydrocortisone—atopic dermatitis	3.87e-05	0.000331	CcSEcCtD
Celecoxib—Tachycardia—Prednisolone—atopic dermatitis	3.87e-05	0.000331	CcSEcCtD
Celecoxib—Hypertension—Triamcinolone—atopic dermatitis	3.85e-05	0.00033	CcSEcCtD
Celecoxib—Hypertension—Methylprednisolone—atopic dermatitis	3.84e-05	0.000329	CcSEcCtD
Celecoxib—Infection—Hydrocortisone—atopic dermatitis	3.84e-05	0.000329	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisolone—atopic dermatitis	3.83e-05	0.000328	CcSEcCtD
Celecoxib—Shock—Hydrocortisone—atopic dermatitis	3.81e-05	0.000326	CcSEcCtD
Celecoxib—Myalgia—Triamcinolone—atopic dermatitis	3.8e-05	0.000325	CcSEcCtD
Celecoxib—Nervous system disorder—Hydrocortisone—atopic dermatitis	3.79e-05	0.000325	CcSEcCtD
Celecoxib—Arthralgia—Methylprednisolone—atopic dermatitis	3.79e-05	0.000325	CcSEcCtD
Celecoxib—Myalgia—Methylprednisolone—atopic dermatitis	3.79e-05	0.000325	CcSEcCtD
Celecoxib—Eye disorder—Prednisone—atopic dermatitis	3.79e-05	0.000324	CcSEcCtD
Celecoxib—Anxiety—Methylprednisolone—atopic dermatitis	3.78e-05	0.000323	CcSEcCtD
Celecoxib—Tachycardia—Hydrocortisone—atopic dermatitis	3.78e-05	0.000323	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	3.76e-05	0.000322	CcSEcCtD
Celecoxib—Flushing—Prednisone—atopic dermatitis	3.76e-05	0.000322	CcSEcCtD
Celecoxib—Skin disorder—Hydrocortisone—atopic dermatitis	3.76e-05	0.000322	CcSEcCtD
Celecoxib—Hyperhidrosis—Hydrocortisone—atopic dermatitis	3.74e-05	0.00032	CcSEcCtD
Celecoxib—Dry mouth—Triamcinolone—atopic dermatitis	3.72e-05	0.000318	CcSEcCtD
Celecoxib—Angioedema—Betamethasone—atopic dermatitis	3.7e-05	0.000317	CcSEcCtD
Celecoxib—Angioedema—Dexamethasone—atopic dermatitis	3.7e-05	0.000317	CcSEcCtD
Celecoxib—Anorexia—Hydrocortisone—atopic dermatitis	3.69e-05	0.000316	CcSEcCtD
Celecoxib—Nausea—Tacrolimus—atopic dermatitis	3.68e-05	0.000315	CcSEcCtD
Celecoxib—Angiopathy—Prednisone—atopic dermatitis	3.68e-05	0.000315	CcSEcCtD
Celecoxib—Confusional state—Methylprednisolone—atopic dermatitis	3.66e-05	0.000314	CcSEcCtD
Celecoxib—Immune system disorder—Prednisone—atopic dermatitis	3.66e-05	0.000313	CcSEcCtD
Celecoxib—Anaphylactic shock—Triamcinolone—atopic dermatitis	3.64e-05	0.000312	CcSEcCtD
Celecoxib—Oedema—Triamcinolone—atopic dermatitis	3.64e-05	0.000312	CcSEcCtD
Celecoxib—Vertigo—Betamethasone—atopic dermatitis	3.64e-05	0.000311	CcSEcCtD
Celecoxib—Vertigo—Dexamethasone—atopic dermatitis	3.64e-05	0.000311	CcSEcCtD
Celecoxib—Anaphylactic shock—Methylprednisolone—atopic dermatitis	3.63e-05	0.000311	CcSEcCtD
Celecoxib—Syncope—Betamethasone—atopic dermatitis	3.63e-05	0.000311	CcSEcCtD
Celecoxib—Syncope—Dexamethasone—atopic dermatitis	3.63e-05	0.000311	CcSEcCtD
Celecoxib—Arrhythmia—Prednisone—atopic dermatitis	3.62e-05	0.00031	CcSEcCtD
Celecoxib—Infection—Triamcinolone—atopic dermatitis	3.62e-05	0.00031	CcSEcCtD
Celecoxib—Infection—Methylprednisolone—atopic dermatitis	3.61e-05	0.000309	CcSEcCtD
Celecoxib—Shock—Triamcinolone—atopic dermatitis	3.58e-05	0.000307	CcSEcCtD
Celecoxib—Insomnia—Prednisolone—atopic dermatitis	3.58e-05	0.000307	CcSEcCtD
Celecoxib—Alopecia—Prednisone—atopic dermatitis	3.58e-05	0.000306	CcSEcCtD
Celecoxib—Shock—Methylprednisolone—atopic dermatitis	3.58e-05	0.000306	CcSEcCtD
Celecoxib—Nervous system disorder—Methylprednisolone—atopic dermatitis	3.56e-05	0.000305	CcSEcCtD
Celecoxib—Loss of consciousness—Betamethasone—atopic dermatitis	3.56e-05	0.000305	CcSEcCtD
Celecoxib—Loss of consciousness—Dexamethasone—atopic dermatitis	3.56e-05	0.000305	CcSEcCtD
Celecoxib—Paraesthesia—Prednisolone—atopic dermatitis	3.56e-05	0.000304	CcSEcCtD
Celecoxib—Tachycardia—Triamcinolone—atopic dermatitis	3.55e-05	0.000304	CcSEcCtD
Celecoxib—Mental disorder—Prednisone—atopic dermatitis	3.55e-05	0.000304	CcSEcCtD
Celecoxib—Tachycardia—Methylprednisolone—atopic dermatitis	3.55e-05	0.000304	CcSEcCtD
Celecoxib—Skin disorder—Methylprednisolone—atopic dermatitis	3.53e-05	0.000302	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.52e-05	0.000302	CcSEcCtD
Celecoxib—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.52e-05	0.000301	CcSEcCtD
Celecoxib—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.51e-05	0.000301	CcSEcCtD
Celecoxib—Insomnia—Hydrocortisone—atopic dermatitis	3.5e-05	0.000299	CcSEcCtD
Celecoxib—Hypertension—Dexamethasone—atopic dermatitis	3.5e-05	0.000299	CcSEcCtD
Celecoxib—Hypertension—Betamethasone—atopic dermatitis	3.5e-05	0.000299	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—CXCR3—atopic dermatitis	3.48e-05	0.000688	CbGpPWpGaD
Celecoxib—Paraesthesia—Hydrocortisone—atopic dermatitis	3.47e-05	0.000297	CcSEcCtD
Celecoxib—Myalgia—Dexamethasone—atopic dermatitis	3.45e-05	0.000295	CcSEcCtD
Celecoxib—Myalgia—Betamethasone—atopic dermatitis	3.45e-05	0.000295	CcSEcCtD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	3.44e-05	0.00068	CbGpPWpGaD
Celecoxib—Anxiety—Dexamethasone—atopic dermatitis	3.44e-05	0.000294	CcSEcCtD
Celecoxib—Anxiety—Betamethasone—atopic dermatitis	3.44e-05	0.000294	CcSEcCtD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—IL6—atopic dermatitis	3.43e-05	0.000679	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL5—atopic dermatitis	3.41e-05	0.000675	CbGpPWpGaD
Celecoxib—Dyspepsia—Hydrocortisone—atopic dermatitis	3.4e-05	0.000291	CcSEcCtD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.39e-05	0.000671	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IFNG—atopic dermatitis	3.39e-05	0.000669	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	3.38e-05	0.000669	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—IL6—atopic dermatitis	3.38e-05	0.000668	CbGpPWpGaD
Celecoxib—Decreased appetite—Hydrocortisone—atopic dermatitis	3.36e-05	0.000288	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	3.36e-05	0.000664	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—MAPK8—atopic dermatitis	3.34e-05	0.000661	CbGpPWpGaD
Celecoxib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.34e-05	0.000286	CcSEcCtD
Celecoxib—Fatigue—Hydrocortisone—atopic dermatitis	3.33e-05	0.000285	CcSEcCtD
Celecoxib—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	3.33e-05	0.000659	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—CXCL8—atopic dermatitis	3.33e-05	0.000658	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	3.32e-05	0.000657	CbGpPWpGaD
Celecoxib—Vision blurred—Prednisone—atopic dermatitis	3.32e-05	0.000284	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.32e-05	0.000284	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.31e-05	0.000283	CcSEcCtD
Celecoxib—Oedema—Betamethasone—atopic dermatitis	3.3e-05	0.000283	CcSEcCtD
Celecoxib—Anaphylactic shock—Betamethasone—atopic dermatitis	3.3e-05	0.000283	CcSEcCtD
Celecoxib—Oedema—Dexamethasone—atopic dermatitis	3.3e-05	0.000283	CcSEcCtD
Celecoxib—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.3e-05	0.000283	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—IL5—atopic dermatitis	3.3e-05	0.000652	CbGpPWpGaD
Celecoxib—Insomnia—Triamcinolone—atopic dermatitis	3.29e-05	0.000282	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.29e-05	0.000651	CbGpPWpGaD
Celecoxib—Insomnia—Methylprednisolone—atopic dermatitis	3.29e-05	0.000281	CcSEcCtD
Celecoxib—Infection—Dexamethasone—atopic dermatitis	3.28e-05	0.000281	CcSEcCtD
Celecoxib—Infection—Betamethasone—atopic dermatitis	3.28e-05	0.000281	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	3.28e-05	0.000648	CbGpPWpGaD
Celecoxib—Paraesthesia—Triamcinolone—atopic dermatitis	3.27e-05	0.00028	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—atopic dermatitis	3.26e-05	0.000279	CcSEcCtD
Celecoxib—Paraesthesia—Methylprednisolone—atopic dermatitis	3.26e-05	0.000279	CcSEcCtD
Celecoxib—Anaemia—Prednisone—atopic dermatitis	3.26e-05	0.000279	CcSEcCtD
Celecoxib—Shock—Dexamethasone—atopic dermatitis	3.25e-05	0.000278	CcSEcCtD
Celecoxib—Shock—Betamethasone—atopic dermatitis	3.25e-05	0.000278	CcSEcCtD
Celecoxib—Dyspnoea—Triamcinolone—atopic dermatitis	3.25e-05	0.000278	CcSEcCtD
Celecoxib—Nervous system disorder—Betamethasone—atopic dermatitis	3.24e-05	0.000277	CcSEcCtD
Celecoxib—Nervous system disorder—Dexamethasone—atopic dermatitis	3.24e-05	0.000277	CcSEcCtD
Celecoxib—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.24e-05	0.000277	CcSEcCtD
Celecoxib—Thrombocytopenia—Betamethasone—atopic dermatitis	3.24e-05	0.000277	CcSEcCtD
Celecoxib—PDPK1—Downstream signal transduction—IL6—atopic dermatitis	3.23e-05	0.000638	CbGpPWpGaD
Celecoxib—Tachycardia—Dexamethasone—atopic dermatitis	3.23e-05	0.000276	CcSEcCtD
Celecoxib—Tachycardia—Betamethasone—atopic dermatitis	3.23e-05	0.000276	CcSEcCtD
Celecoxib—Angioedema—Prednisone—atopic dermatitis	3.22e-05	0.000276	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	3.22e-05	0.000637	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—IL6—atopic dermatitis	3.21e-05	0.000635	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—DEFB1—atopic dermatitis	3.21e-05	0.000634	CbGpPWpGaD
Celecoxib—Dyspepsia—Triamcinolone—atopic dermatitis	3.21e-05	0.000274	CcSEcCtD
Celecoxib—MAPK14—Signaling by NGF—NGF—atopic dermatitis	3.2e-05	0.000634	CbGpPWpGaD
Celecoxib—Dyspepsia—Methylprednisolone—atopic dermatitis	3.2e-05	0.000274	CcSEcCtD
Celecoxib—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.19e-05	0.000273	CcSEcCtD
Celecoxib—Hyperhidrosis—Betamethasone—atopic dermatitis	3.19e-05	0.000273	CcSEcCtD
Celecoxib—PDPK1—Signaling by ERBB2—IL6—atopic dermatitis	3.19e-05	0.000632	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—MAPK8—atopic dermatitis	3.19e-05	0.000631	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KIF3A—atopic dermatitis	3.19e-05	0.000631	CbGpPWpGaD
Celecoxib—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.19e-05	0.000273	CcSEcCtD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.19e-05	0.00063	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CASP1—atopic dermatitis	3.18e-05	0.000629	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—IL6—atopic dermatitis	3.18e-05	0.000629	CbGpPWpGaD
Celecoxib—Vertigo—Prednisone—atopic dermatitis	3.17e-05	0.000271	CcSEcCtD
Celecoxib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.16e-05	0.000271	CcSEcCtD
Celecoxib—Syncope—Prednisone—atopic dermatitis	3.16e-05	0.000271	CcSEcCtD
Celecoxib—Anorexia—Dexamethasone—atopic dermatitis	3.15e-05	0.00027	CcSEcCtD
Celecoxib—Anorexia—Betamethasone—atopic dermatitis	3.15e-05	0.00027	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—atopic dermatitis	3.15e-05	0.000269	CcSEcCtD
Celecoxib—Fatigue—Triamcinolone—atopic dermatitis	3.14e-05	0.000269	CcSEcCtD
Celecoxib—Fatigue—Methylprednisolone—atopic dermatitis	3.13e-05	0.000268	CcSEcCtD
Celecoxib—MAPK14—Cell-Cell communication—MAPK8—atopic dermatitis	3.11e-05	0.000616	CbGpPWpGaD
Celecoxib—Loss of consciousness—Prednisone—atopic dermatitis	3.1e-05	0.000265	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.1e-05	0.000612	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	3.09e-05	0.000611	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—MAPK8—atopic dermatitis	3.08e-05	0.000608	CbGpPWpGaD
Celecoxib—Urticaria—Hydrocortisone—atopic dermatitis	3.07e-05	0.000263	CcSEcCtD
Celecoxib—Abdominal pain—Hydrocortisone—atopic dermatitis	3.06e-05	0.000262	CcSEcCtD
Celecoxib—Body temperature increased—Hydrocortisone—atopic dermatitis	3.06e-05	0.000262	CcSEcCtD
Celecoxib—Hypertension—Prednisone—atopic dermatitis	3.04e-05	0.000261	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—IL1B—atopic dermatitis	3.02e-05	0.000597	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL5—atopic dermatitis	3.01e-05	0.000596	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.01e-05	0.000258	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.01e-05	0.000258	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—IL2—atopic dermatitis	3.01e-05	0.000595	CbGpPWpGaD
Celecoxib—Myalgia—Prednisone—atopic dermatitis	3e-05	0.000257	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—atopic dermatitis	3e-05	0.000257	CcSEcCtD
Celecoxib—Feeling abnormal—Triamcinolone—atopic dermatitis	3e-05	0.000257	CcSEcCtD
Celecoxib—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.99e-05	0.000256	CcSEcCtD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	2.99e-05	0.000592	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	2.99e-05	0.000592	CbGpPWpGaD
Celecoxib—Anxiety—Prednisone—atopic dermatitis	2.99e-05	0.000256	CcSEcCtD
Celecoxib—PDPK1—DAP12 interactions—IL6—atopic dermatitis	2.99e-05	0.000591	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.99e-05	0.000591	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—IL6—atopic dermatitis	2.99e-05	0.000591	CbGpPWpGaD
Celecoxib—Insomnia—Betamethasone—atopic dermatitis	2.99e-05	0.000256	CcSEcCtD
Celecoxib—Insomnia—Dexamethasone—atopic dermatitis	2.99e-05	0.000256	CcSEcCtD
Celecoxib—MAPK14—Hemostasis—IL5—atopic dermatitis	2.99e-05	0.000591	CbGpPWpGaD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.98e-05	0.000255	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.97e-05	0.000254	CcSEcCtD
Celecoxib—Paraesthesia—Betamethasone—atopic dermatitis	2.97e-05	0.000254	CcSEcCtD
Celecoxib—Paraesthesia—Dexamethasone—atopic dermatitis	2.97e-05	0.000254	CcSEcCtD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	2.97e-05	0.000586	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—IL6—atopic dermatitis	2.96e-05	0.000586	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	2.95e-05	0.000584	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	2.94e-05	0.000581	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—MAPK8—atopic dermatitis	2.93e-05	0.000579	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—IL6—atopic dermatitis	2.92e-05	0.000578	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	2.92e-05	0.000577	CbGpPWpGaD
Celecoxib—Hypersensitivity—Prednisolone—atopic dermatitis	2.92e-05	0.00025	CcSEcCtD
Celecoxib—Dyspepsia—Dexamethasone—atopic dermatitis	2.91e-05	0.000249	CcSEcCtD
Celecoxib—Dyspepsia—Betamethasone—atopic dermatitis	2.91e-05	0.000249	CcSEcCtD
Celecoxib—PDPK1—Innate Immune System—NFKBIA—atopic dermatitis	2.9e-05	0.000574	CbGpPWpGaD
Celecoxib—Urticaria—Triamcinolone—atopic dermatitis	2.89e-05	0.000248	CcSEcCtD
Celecoxib—Urticaria—Methylprednisolone—atopic dermatitis	2.89e-05	0.000247	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—CCL11—atopic dermatitis	2.88e-05	0.00057	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CMA1—atopic dermatitis	2.88e-05	0.00057	CbGpPWpGaD
Celecoxib—Body temperature increased—Triamcinolone—atopic dermatitis	2.88e-05	0.000246	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—atopic dermatitis	2.88e-05	0.000246	CcSEcCtD
Celecoxib—Oedema—Prednisone—atopic dermatitis	2.88e-05	0.000246	CcSEcCtD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	2.88e-05	0.000569	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TLR2—atopic dermatitis	2.87e-05	0.000568	CbGpPWpGaD
Celecoxib—Abdominal pain—Methylprednisolone—atopic dermatitis	2.87e-05	0.000246	CcSEcCtD
Celecoxib—Decreased appetite—Dexamethasone—atopic dermatitis	2.87e-05	0.000246	CcSEcCtD
Celecoxib—Decreased appetite—Betamethasone—atopic dermatitis	2.87e-05	0.000246	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—MAPK8—atopic dermatitis	2.87e-05	0.000568	CbGpPWpGaD
Celecoxib—Infection—Prednisone—atopic dermatitis	2.86e-05	0.000245	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.85e-05	0.000244	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.85e-05	0.000244	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.85e-05	0.000244	CcSEcCtD
Celecoxib—Fatigue—Dexamethasone—atopic dermatitis	2.85e-05	0.000244	CcSEcCtD
Celecoxib—Fatigue—Betamethasone—atopic dermatitis	2.85e-05	0.000244	CcSEcCtD
Celecoxib—MAPK14—Innate Immune System—CASP1—atopic dermatitis	2.84e-05	0.000561	CbGpPWpGaD
Celecoxib—Shock—Prednisone—atopic dermatitis	2.83e-05	0.000242	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—atopic dermatitis	2.82e-05	0.000242	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—CXCL10—atopic dermatitis	2.81e-05	0.000556	CbGpPWpGaD
Celecoxib—Tachycardia—Prednisone—atopic dermatitis	2.81e-05	0.00024	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—atopic dermatitis	2.8e-05	0.000239	CcSEcCtD
Celecoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	2.79e-05	0.000553	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NFKBIA—atopic dermatitis	2.78e-05	0.000551	CbGpPWpGaD
Celecoxib—Hyperhidrosis—Prednisone—atopic dermatitis	2.78e-05	0.000238	CcSEcCtD
Celecoxib—Asthenia—Hydrocortisone—atopic dermatitis	2.78e-05	0.000238	CcSEcCtD
Celecoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	2.77e-05	0.000547	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—IL1B—atopic dermatitis	2.77e-05	0.000547	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.74e-05	0.000543	CbGpPWpGaD
Celecoxib—Anorexia—Prednisone—atopic dermatitis	2.74e-05	0.000235	CcSEcCtD
Celecoxib—Pruritus—Hydrocortisone—atopic dermatitis	2.74e-05	0.000234	CcSEcCtD
Celecoxib—Feeling abnormal—Betamethasone—atopic dermatitis	2.72e-05	0.000233	CcSEcCtD
Celecoxib—Feeling abnormal—Dexamethasone—atopic dermatitis	2.72e-05	0.000233	CcSEcCtD
Celecoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	2.72e-05	0.000537	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT6—atopic dermatitis	2.71e-05	0.000536	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD79A—atopic dermatitis	2.7e-05	0.000534	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.7e-05	0.000231	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.7e-05	0.000231	CcSEcCtD
Celecoxib—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	2.69e-05	0.000533	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	2.69e-05	0.000532	CbGpPWpGaD
Celecoxib—Hypersensitivity—Triamcinolone—atopic dermatitis	2.68e-05	0.00023	CcSEcCtD
Celecoxib—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.68e-05	0.000229	CcSEcCtD
Celecoxib—MAPK14—TCR Signaling Pathway—IL6—atopic dermatitis	2.67e-05	0.000528	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CCL5—atopic dermatitis	2.67e-05	0.000527	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—CXCL8—atopic dermatitis	2.66e-05	0.000526	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.65e-05	0.000524	CbGpPWpGaD
Celecoxib—Diarrhoea—Hydrocortisone—atopic dermatitis	2.65e-05	0.000227	CcSEcCtD
Celecoxib—MAPK14—Signaling by NGF—NFKBIA—atopic dermatitis	2.64e-05	0.000523	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—MAPK8—atopic dermatitis	2.64e-05	0.000522	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	2.63e-05	0.00052	CbGpPWpGaD
Celecoxib—Urticaria—Betamethasone—atopic dermatitis	2.63e-05	0.000225	CcSEcCtD
Celecoxib—Urticaria—Dexamethasone—atopic dermatitis	2.63e-05	0.000225	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	2.62e-05	0.000519	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.62e-05	0.000224	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—atopic dermatitis	2.62e-05	0.000224	CcSEcCtD
Celecoxib—PDPK1—Innate Immune System—CASP8—atopic dermatitis	2.62e-05	0.000517	CbGpPWpGaD
Celecoxib—Asthenia—Triamcinolone—atopic dermatitis	2.61e-05	0.000224	CcSEcCtD
Celecoxib—Body temperature increased—Betamethasone—atopic dermatitis	2.61e-05	0.000224	CcSEcCtD
Celecoxib—Abdominal pain—Dexamethasone—atopic dermatitis	2.61e-05	0.000224	CcSEcCtD
Celecoxib—Body temperature increased—Dexamethasone—atopic dermatitis	2.61e-05	0.000224	CcSEcCtD
Celecoxib—Abdominal pain—Betamethasone—atopic dermatitis	2.61e-05	0.000224	CcSEcCtD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	2.61e-05	0.000517	CbGpPWpGaD
Celecoxib—Asthenia—Methylprednisolone—atopic dermatitis	2.61e-05	0.000223	CcSEcCtD
Celecoxib—Insomnia—Prednisone—atopic dermatitis	2.6e-05	0.000223	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—atopic dermatitis	2.58e-05	0.000221	CcSEcCtD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	2.58e-05	0.00051	CbGpPWpGaD
Celecoxib—Pruritus—Triamcinolone—atopic dermatitis	2.58e-05	0.000221	CcSEcCtD
Celecoxib—Pruritus—Methylprednisolone—atopic dermatitis	2.57e-05	0.00022	CcSEcCtD
Celecoxib—MAPK14—Innate Immune System—TLR2—atopic dermatitis	2.56e-05	0.000507	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KIF3A—atopic dermatitis	2.56e-05	0.000507	CbGpPWpGaD
Celecoxib—Dizziness—Hydrocortisone—atopic dermatitis	2.56e-05	0.000219	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—MAPK8—atopic dermatitis	2.54e-05	0.000502	CbGpPWpGaD
Celecoxib—Dyspepsia—Prednisone—atopic dermatitis	2.53e-05	0.000217	CcSEcCtD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	2.53e-05	0.0005	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KIF3A—atopic dermatitis	2.53e-05	0.0005	CbGpPWpGaD
Celecoxib—Decreased appetite—Prednisone—atopic dermatitis	2.5e-05	0.000214	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—FCER2—atopic dermatitis	2.5e-05	0.000495	CbGpPWpGaD
Celecoxib—Rash—Prednisolone—atopic dermatitis	2.5e-05	0.000214	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—atopic dermatitis	2.49e-05	0.000214	CcSEcCtD
Celecoxib—Diarrhoea—Methylprednisolone—atopic dermatitis	2.49e-05	0.000213	CcSEcCtD
Celecoxib—Fatigue—Prednisone—atopic dermatitis	2.48e-05	0.000212	CcSEcCtD
Celecoxib—Headache—Prednisolone—atopic dermatitis	2.48e-05	0.000212	CcSEcCtD
Celecoxib—MAPK14—MyD88-independent cascade—IL6—atopic dermatitis	2.47e-05	0.000489	CbGpPWpGaD
Celecoxib—Constipation—Prednisone—atopic dermatitis	2.46e-05	0.000211	CcSEcCtD
Celecoxib—Vomiting—Hydrocortisone—atopic dermatitis	2.46e-05	0.000211	CcSEcCtD
Celecoxib—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	2.44e-05	0.000483	CbGpPWpGaD
Celecoxib—Rash—Hydrocortisone—atopic dermatitis	2.44e-05	0.000209	CcSEcCtD
Celecoxib—Dermatitis—Hydrocortisone—atopic dermatitis	2.44e-05	0.000209	CcSEcCtD
Celecoxib—Headache—Hydrocortisone—atopic dermatitis	2.42e-05	0.000207	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—CCL5—atopic dermatitis	2.42e-05	0.000479	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	2.41e-05	0.000478	CbGpPWpGaD
Celecoxib—Dizziness—Triamcinolone—atopic dermatitis	2.41e-05	0.000206	CcSEcCtD
Celecoxib—Dizziness—Methylprednisolone—atopic dermatitis	2.4e-05	0.000206	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—CCR5—atopic dermatitis	2.4e-05	0.000475	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	2.4e-05	0.000474	CbGpPWpGaD
Celecoxib—Feeling abnormal—Prednisone—atopic dermatitis	2.37e-05	0.000203	CcSEcCtD
Celecoxib—Asthenia—Dexamethasone—atopic dermatitis	2.37e-05	0.000203	CcSEcCtD
Celecoxib—Asthenia—Betamethasone—atopic dermatitis	2.37e-05	0.000203	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	2.36e-05	0.000467	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Prednisone—atopic dermatitis	2.35e-05	0.000201	CcSEcCtD
Celecoxib—Nausea—Prednisolone—atopic dermatitis	2.35e-05	0.000201	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—CCR3—atopic dermatitis	2.35e-05	0.000465	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	2.34e-05	0.000464	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PPARA—atopic dermatitis	2.34e-05	0.000463	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—MAPK8—atopic dermatitis	2.34e-05	0.000462	CbGpPWpGaD
Celecoxib—Pruritus—Betamethasone—atopic dermatitis	2.34e-05	0.0002	CcSEcCtD
Celecoxib—Pruritus—Dexamethasone—atopic dermatitis	2.34e-05	0.0002	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	2.34e-05	0.000462	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	2.34e-05	0.000462	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.33e-05	0.000461	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL22—atopic dermatitis	2.33e-05	0.00046	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	2.32e-05	0.00046	CbGpPWpGaD
Celecoxib—Vomiting—Triamcinolone—atopic dermatitis	2.32e-05	0.000198	CcSEcCtD
Celecoxib—Vomiting—Methylprednisolone—atopic dermatitis	2.31e-05	0.000198	CcSEcCtD
Celecoxib—Nausea—Hydrocortisone—atopic dermatitis	2.3e-05	0.000197	CcSEcCtD
Celecoxib—Rash—Triamcinolone—atopic dermatitis	2.3e-05	0.000197	CcSEcCtD
Celecoxib—Dermatitis—Triamcinolone—atopic dermatitis	2.29e-05	0.000196	CcSEcCtD
Celecoxib—Rash—Methylprednisolone—atopic dermatitis	2.29e-05	0.000196	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.29e-05	0.000453	CbGpPWpGaD
Celecoxib—Dermatitis—Methylprednisolone—atopic dermatitis	2.29e-05	0.000196	CcSEcCtD
Celecoxib—Urticaria—Prednisone—atopic dermatitis	2.29e-05	0.000196	CcSEcCtD
Celecoxib—CA6—Metabolism—PPARA—atopic dermatitis	2.28e-05	0.000451	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PPARA—atopic dermatitis	2.28e-05	0.000451	CbGpPWpGaD
Celecoxib—Headache—Triamcinolone—atopic dermatitis	2.28e-05	0.000195	CcSEcCtD
Celecoxib—Headache—Methylprednisolone—atopic dermatitis	2.28e-05	0.000195	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—atopic dermatitis	2.28e-05	0.000195	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—atopic dermatitis	2.28e-05	0.000195	CcSEcCtD
Celecoxib—Diarrhoea—Betamethasone—atopic dermatitis	2.26e-05	0.000194	CcSEcCtD
Celecoxib—Diarrhoea—Dexamethasone—atopic dermatitis	2.26e-05	0.000194	CcSEcCtD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.25e-05	0.000444	CbGpPWpGaD
Celecoxib—MAPK14—Activated TLR4 signalling—IL6—atopic dermatitis	2.23e-05	0.00044	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	2.21e-05	0.000438	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL18—atopic dermatitis	2.21e-05	0.000437	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—IL2—atopic dermatitis	2.2e-05	0.000434	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—IL6—atopic dermatitis	2.19e-05	0.000434	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TNF—atopic dermatitis	2.19e-05	0.000433	CbGpPWpGaD
Celecoxib—Dizziness—Dexamethasone—atopic dermatitis	2.19e-05	0.000187	CcSEcCtD
Celecoxib—Dizziness—Betamethasone—atopic dermatitis	2.19e-05	0.000187	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—CCR5—atopic dermatitis	2.18e-05	0.000431	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT6—atopic dermatitis	2.18e-05	0.000431	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD8A—atopic dermatitis	2.18e-05	0.000431	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	2.17e-05	0.00043	CbGpPWpGaD
Celecoxib—Nausea—Triamcinolone—atopic dermatitis	2.16e-05	0.000185	CcSEcCtD
Celecoxib—Nausea—Methylprednisolone—atopic dermatitis	2.16e-05	0.000185	CcSEcCtD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	2.15e-05	0.000425	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CD4—atopic dermatitis	2.15e-05	0.000425	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PPARA—atopic dermatitis	2.13e-05	0.000421	CbGpPWpGaD
Celecoxib—Hypersensitivity—Prednisone—atopic dermatitis	2.12e-05	0.000182	CcSEcCtD
Celecoxib—MAPK14—Immune System—CARD11—atopic dermatitis	2.12e-05	0.000419	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.1e-05	0.000416	CbGpPWpGaD
Celecoxib—Vomiting—Dexamethasone—atopic dermatitis	2.1e-05	0.00018	CcSEcCtD
Celecoxib—Vomiting—Betamethasone—atopic dermatitis	2.1e-05	0.00018	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—TAC1—atopic dermatitis	2.1e-05	0.000414	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NPS—atopic dermatitis	2.1e-05	0.000414	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	2.09e-05	0.000414	CbGpPWpGaD
Celecoxib—Rash—Betamethasone—atopic dermatitis	2.08e-05	0.000178	CcSEcCtD
Celecoxib—Rash—Dexamethasone—atopic dermatitis	2.08e-05	0.000178	CcSEcCtD
Celecoxib—Dermatitis—Dexamethasone—atopic dermatitis	2.08e-05	0.000178	CcSEcCtD
Celecoxib—Dermatitis—Betamethasone—atopic dermatitis	2.08e-05	0.000178	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—CCL27—atopic dermatitis	2.07e-05	0.00041	CbGpPWpGaD
Celecoxib—Headache—Dexamethasone—atopic dermatitis	2.07e-05	0.000177	CcSEcCtD
Celecoxib—Headache—Betamethasone—atopic dermatitis	2.07e-05	0.000177	CcSEcCtD
Celecoxib—Asthenia—Prednisone—atopic dermatitis	2.06e-05	0.000177	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—CD4—atopic dermatitis	2.06e-05	0.000408	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCR3—atopic dermatitis	2.06e-05	0.000406	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—IL6—atopic dermatitis	2.04e-05	0.000403	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SELE—atopic dermatitis	2.04e-05	0.000403	CbGpPWpGaD
Celecoxib—Pruritus—Prednisone—atopic dermatitis	2.04e-05	0.000174	CcSEcCtD
Celecoxib—MAPK14—Cellular responses to stress—CXCL8—atopic dermatitis	2.01e-05	0.000397	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—atopic dermatitis	2.01e-05	0.000397	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PPARA—atopic dermatitis	1.97e-05	0.00039	CbGpPWpGaD
Celecoxib—Diarrhoea—Prednisone—atopic dermatitis	1.97e-05	0.000169	CcSEcCtD
Celecoxib—Nausea—Betamethasone—atopic dermatitis	1.96e-05	0.000168	CcSEcCtD
Celecoxib—Nausea—Dexamethasone—atopic dermatitis	1.96e-05	0.000168	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—IL5—atopic dermatitis	1.95e-05	0.000385	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PPARA—atopic dermatitis	1.93e-05	0.000382	CbGpPWpGaD
Celecoxib—Dizziness—Prednisone—atopic dermatitis	1.9e-05	0.000163	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	1.89e-05	0.000373	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.87e-05	0.00037	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—IL6—atopic dermatitis	1.87e-05	0.00037	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—IL6—atopic dermatitis	1.86e-05	0.000369	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL17—atopic dermatitis	1.86e-05	0.000368	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CCR5—atopic dermatitis	1.84e-05	0.000364	CbGpPWpGaD
Celecoxib—Vomiting—Prednisone—atopic dermatitis	1.83e-05	0.000157	CcSEcCtD
Celecoxib—PDPK1—Innate Immune System—MAPK8—atopic dermatitis	1.82e-05	0.00036	CbGpPWpGaD
Celecoxib—Rash—Prednisone—atopic dermatitis	1.81e-05	0.000155	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—atopic dermatitis	1.81e-05	0.000155	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.81e-05	0.000358	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GLB1—atopic dermatitis	1.8e-05	0.000357	CbGpPWpGaD
Celecoxib—Headache—Prednisone—atopic dermatitis	1.8e-05	0.000154	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—IL6—atopic dermatitis	1.77e-05	0.00035	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—MAPK8—atopic dermatitis	1.77e-05	0.000349	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.75e-05	0.000346	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	1.74e-05	0.000344	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	1.74e-05	0.000343	CbGpPWpGaD
Celecoxib—Nausea—Prednisone—atopic dermatitis	1.71e-05	0.000146	CcSEcCtD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	1.7e-05	0.000336	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NFKBIA—atopic dermatitis	1.69e-05	0.000334	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL10—atopic dermatitis	1.66e-05	0.000329	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—MAPK8—atopic dermatitis	1.66e-05	0.000328	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KIF3A—atopic dermatitis	1.66e-05	0.000328	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CASP1—atopic dermatitis	1.65e-05	0.000327	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARA—atopic dermatitis	1.57e-05	0.000311	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL5—atopic dermatitis	1.57e-05	0.00031	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL5—atopic dermatitis	1.54e-05	0.000305	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CASP8—atopic dermatitis	1.52e-05	0.000301	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GLB1—atopic dermatitis	1.51e-05	0.000299	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARA—atopic dermatitis	1.51e-05	0.000298	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NFKBIA—atopic dermatitis	1.51e-05	0.000298	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CMA1—atopic dermatitis	1.5e-05	0.000296	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL11—atopic dermatitis	1.5e-05	0.000296	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR2—atopic dermatitis	1.49e-05	0.000295	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—atopic dermatitis	1.49e-05	0.000295	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.46e-05	0.000289	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.45e-05	0.000287	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADSL—atopic dermatitis	1.45e-05	0.000286	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCL5—atopic dermatitis	1.43e-05	0.000283	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT6—atopic dermatitis	1.41e-05	0.000279	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	1.4e-05	0.000278	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—atopic dermatitis	1.4e-05	0.000278	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—atopic dermatitis	1.39e-05	0.000274	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	1.38e-05	0.000272	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	1.37e-05	0.000272	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CASP8—atopic dermatitis	1.36e-05	0.000269	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NGF—atopic dermatitis	1.32e-05	0.000262	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.32e-05	0.000261	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—atopic dermatitis	1.3e-05	0.000258	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—atopic dermatitis	1.3e-05	0.000256	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCR5—atopic dermatitis	1.29e-05	0.000255	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARA—atopic dermatitis	1.27e-05	0.000252	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—atopic dermatitis	1.26e-05	0.000249	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—atopic dermatitis	1.25e-05	0.000247	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GLB1—atopic dermatitis	1.22e-05	0.000242	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR3—atopic dermatitis	1.22e-05	0.000242	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC11A1—atopic dermatitis	1.21e-05	0.000239	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADSL—atopic dermatitis	1.17e-05	0.000232	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—atopic dermatitis	1.16e-05	0.00023	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.16e-05	0.000229	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—atopic dermatitis	1.16e-05	0.000229	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—atopic dermatitis	1.16e-05	0.000228	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—atopic dermatitis	1.15e-05	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—atopic dermatitis	1.15e-05	0.000227	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.14e-05	0.000226	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—atopic dermatitis	1.14e-05	0.000226	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—atopic dermatitis	1.13e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—atopic dermatitis	1.13e-05	0.000223	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—atopic dermatitis	1.12e-05	0.000221	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.1e-05	0.000218	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.09e-05	0.000216	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TAC1—atopic dermatitis	1.09e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NPS—atopic dermatitis	1.09e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR3—atopic dermatitis	1.07e-05	0.000211	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK8—atopic dermatitis	1.06e-05	0.00021	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—atopic dermatitis	1.06e-05	0.000209	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL5—atopic dermatitis	1.01e-05	0.0002	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.01e-05	0.0002	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GLB1—atopic dermatitis	1e-05	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARA—atopic dermatitis	9.87e-06	0.000195	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADSL—atopic dermatitis	9.68e-06	0.000191	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADSL—atopic dermatitis	9.59e-06	0.00019	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK8—atopic dermatitis	9.45e-06	0.000187	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.91e-06	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKBIA—atopic dermatitis	8.78e-06	0.000174	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL10—atopic dermatitis	8.63e-06	0.000171	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—atopic dermatitis	8.47e-06	0.000168	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.47e-06	0.000168	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CASP8—atopic dermatitis	7.92e-06	0.000157	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—atopic dermatitis	7.79e-06	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—atopic dermatitis	7.44e-06	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL5—atopic dermatitis	7.43e-06	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—atopic dermatitis	7.41e-06	0.000146	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.29e-06	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGF—atopic dermatitis	6.88e-06	0.000136	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—atopic dermatitis	6.85e-06	0.000135	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—atopic dermatitis	6.84e-06	0.000135	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—atopic dermatitis	6.77e-06	0.000134	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—atopic dermatitis	6.73e-06	0.000133	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—atopic dermatitis	6.69e-06	0.000132	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.6e-06	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—atopic dermatitis	6.5e-06	0.000129	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.33e-06	0.000125	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—atopic dermatitis	6.25e-06	0.000124	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—atopic dermatitis	6.11e-06	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—atopic dermatitis	6.04e-06	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—atopic dermatitis	6.01e-06	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—atopic dermatitis	5.98e-06	0.000118	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—atopic dermatitis	5.9e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKBIA—atopic dermatitis	5.68e-06	0.000112	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—atopic dermatitis	5.51e-06	0.000109	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARA—atopic dermatitis	4.9e-06	9.7e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—atopic dermatitis	4.38e-06	8.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—atopic dermatitis	4.05e-06	8e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARA—atopic dermatitis	3.97e-06	7.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—atopic dermatitis	3.87e-06	7.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—atopic dermatitis	3.84e-06	7.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—atopic dermatitis	3.56e-06	7.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—atopic dermatitis	3.52e-06	6.95e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.28e-06	6.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.25e-06	6.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—atopic dermatitis	2.27e-06	4.5e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.14e-06	4.24e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—atopic dermatitis	2.07e-06	4.1e-05	CbGpPWpGaD
